Leopold, Stephanie A. Zeilbeck, Ludwig F. Weber, Gregor Seitz, Roswitha Bösl, Michael R. Jägle, Herbert Fuchshofer, Rudolf Tamm, Ernst R. and Ohlmann, Andreas 2017. Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma. Scientific Reports, Vol. 7, Issue. 1,
Vohra, Ravneet Batra, Abhinandan Forbes, Sean C. Vandenborne, Krista and Walter, Glenn A. 2017. Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds. The American Journal of Pathology, Vol. 187, Issue. 9, p. 2060.
Cwerman-Thibault, Hélène Lechauve, Christophe Augustin, Sébastien Roussel, Delphine Reboussin, Élodie Mohammad, Ammara Degardin-Chicaud, Julie Simonutti, Manuel Liang, Hong Brignole-Baudouin, Françoise Maron, Anne Debeir, Thomas and Corral-Debrinski, Marisol 2017. Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice. Molecular Therapy - Methods & Clinical Development, Vol. 5, p. 200.
Nivison, Mary P. Ericson, Nolan G. Green, Virginia M. Bielas, Jason H. Campbell, Jean S. and Horner, Philip J. 2017. Age-related accumulation of phosphorylated mitofusin 2 protein in retinal ganglion cells correlates with glaucoma progression. Experimental Neurology, Vol. 296, p. 49.
Carreon, Teresia A. Edwards, Genea Wang, Haiyan and Bhattacharya, Sanjoy K. 2017. Segmental outflow of aqueous humor in mouse and human. Experimental Eye Research, Vol. 158, p. 59.
Anders, Fabian Teister, Julia Liu, Aiwei Funke, Sebastian Grus, Franz H. Thanos, Solon von Pein, Harald D. Pfeiffer, Norbert Prokosch, Verena and Cho, Kin-Sang 2017. Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma. PLOS ONE, Vol. 12, Issue. 4, p. e0175451.
Williams, Pete A. Harder, Jeffrey M. Foxworth, Nicole E. Cardozo, Brynn H. Cochran, Kelly E. and John, Simon W. M. 2017. Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma. Frontiers in Neuroscience, Vol. 11,
Williams, Pete A. Braine, Catherine E. Foxworth, Nicole E. Cochran, Kelly E. and John, Simon W. M. 2017. GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma. Journal of Neuroinflammation, Vol. 14, Issue. 1,
Barzago, Maria Monica Kurosaki, Mami Fratelli, Maddalena Bolis, Marco Giudice, Chiara Nordio, Laura Cerri, Elisa Domenici, Luciano Terao, Mineko and Garattini, Enrico 2017. Generation of a new mouse model of glaucoma characterized by reduced expression of the AP-2β and AP-2δ proteins. Scientific Reports, Vol. 7, Issue. 1,
Turner, Anita J Vander Wall, Roshana Gupta, Vivek Klistorner, Alex and Graham, Stuart L 2017. DBA/2J mouse model for experimental glaucoma: pitfalls and problems. Clinical & Experimental Ophthalmology,
Meyer, Kacie J. and Anderson, Michael G. 2017. Genetic modifiers as relevant biological variables of eye disorders. Human Molecular Genetics, Vol. 26, Issue. R1, p. R58.
Williams, Pete A. Harder, Jeffrey M. Foxworth, Nicole E. Cochran, Kelly E. Philip, Vivek M. Porciatti, Vittorio Smithies, Oliver and John, Simon W. M. 2017. Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice . Science, Vol. 355, Issue. 6326, p. 756.
Shen, Anna L. Moran, Susan M. Glover, Edward A. Teixeira, Leandro B. Bradfield, Christopher A. and Anderson, Michael G 2017. Retinal pathology in the PPCD1 mouse. PLOS ONE, Vol. 12, Issue. 10, p. e0185094.
Sun, Daniel Moore, Sara and Jakobs, Tatjana C. 2017. Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries. The Journal of Experimental Medicine, Vol. 214, Issue. 5, p. 1411.
Benowitz, Larry I. He, Zhigang and Goldberg, Jeffrey L. 2017. Reaching the brain: Advances in optic nerve regeneration. Experimental Neurology, Vol. 287, p. 365.
Bordone, Melina P. González Fleitas, María F. Pasquini, Laura A. Bosco, Alejandra Sande, Pablo H. Rosenstein, Ruth E. and Dorfman, Damián 2017. Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma. Journal of Neurochemistry, Vol. 142, Issue. 2, p. 323.
Harder, Jeffrey M. Braine, Catherine E. Williams, Pete A. Zhu, Xianjun MacNicoll, Katharine H. Sousa, Gregory L. Buchanan, Rebecca A. Smith, Richard S. Libby, Richard T. Howell, Gareth R. and John, Simon W. M. 2017. Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective. Proceedings of the National Academy of Sciences, Vol. 114, Issue. 19, p. E3839.
Yang, Shuang Zhang, Guoqing Liu, Wan Wang, Zhen Zhang, Jifeng Yang, Dongshan Chen, Y. Eugene Sun, Hong and Li, Yixue 2017. SysFinder: A customized platform for search, comparison and assisted design of appropriate animal models based on systematic similarity. Journal of Genetics and Genomics, Vol. 44, Issue. 5, p. 251.
Fonseca, Begoña Martínez-Águila, Alejandro de Lara, María J. Pérez and Pintor, Jesús 2017. Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma. Purinergic Signalling, Vol. 13, Issue. 2, p. 171.
The glaucomas are neurodegenerative diseases involving death of retinal ganglion cells and optic nerve head excavation. A major risk factor for this neurodegeneration is a harmfully elevated intraocular pressure (IOP). Human glaucomas are typically complex, progressive diseases that are prevalent in the elderly. Family history and genetic factors are clearly important in human glaucoma. Mouse studies have proven helpful for investigating the genetic and mechanistic basis of complex diseases. We previously reported inherited, age-related progressive glaucoma in DBA/2J mice. Here, we report our updated findings from studying the disease in a large number of DBA/2J mice. The period when mice have elevated IOP extends from 6 months to 16 months, with 8–9 months representing an important transition to high IOP for many mice. Optic nerve degeneration follows IOP elevation, with the majority of optic nerves being severely damaged by 12 months of age. This information should help with the design of experiments, and we present the data in a manner that will be useful for future studies of retinal ganglion cell degeneration and optic neuropathy.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 19th November 2017. This data will be updated every 24 hours.